Home/Filings/4/0001209191-21-051759
4//SEC Filing

Dispersyn Gerrit 4

Accession 0001209191-21-051759

CIK 0001533040other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 9:11 AM ET

Size

4.8 KB

Accession

0001209191-21-051759

Insider Transaction Report

Form 4
Period: 2021-08-16
Dispersyn Gerrit
Chief Development Officer
Transactions
  • Purchase

    Common stock, $0.0001 par value

    2021-08-16$1.63/sh+6,000$9,78095,281 total
Footnotes (1)
  • [F1]Includes shares of common stock underlying unvested restricted stock units.

Issuer

Phio Pharmaceuticals Corp.

CIK 0001533040

Entity typeother

Related Parties

1
  • filerCIK 0001704417

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 9:11 AM ET
Size
4.8 KB